AngelaMDaviesMD

Hematology • Aurora, CO

Physician

Join to view full profile

Dr. Davies is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Davies' full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000
Is this information wrong?

Education & Training

Michael G. DeGroote School of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 2001 - Present
CT State Medical License 2013 - 2023
CO State Medical License 2008 - 2021

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction Start of enrollment: 2003 Oct 01
Completed
Phase 1
Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy Start of enrollment: 2003 Sep 01
Completed
Phase 2
S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer Start of enrollment: 2004 Mar 01
Terminated
Phase 2
Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2004 Jan 01
Completed
Phase 2
Cetuximab in Treating Patients With Advanced Solid Tumors Start of enrollment: 2004 Dec 01
Completed
Phase 1
Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors Start of enrollment: 2004 Dec 01
Completed
Phase 1
Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors Start of enrollment: 2005 Mar 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

16 citations
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Narendra Bharathy, Noah E. Berlow, Eric Wang, Jinu Abraham, Teagan P. Settelmeyer, Jody E. Hooper, Matthew N. Svalina, Zia Bajwa, Martin Goros, Brian Hernandez, Johann...> ;Skeletal Muscle. 2019 May 21
45 citations
The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma
Narendra Bharathy, Noah E. Berlow, Eric Wang, Jinu Abraham, Teagan P. Settelmeyer, Jody E. Hooper, Matthew N. Svalina, Yoshihiro Ishikawa, Keith D. Zientek, Zia Bajwa,...> ;Science Signaling. 2018 Nov 20
187 citations
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
Evgeny Izumchenko, K. Paz, D. Ciznadija, Ido Sloma, Amos Katz, David Vasquez-Dunddel, Ido Ben-Zvi, Justin Stebbing, William P. McGuire, William P. Harris, Robert G. Ma...> ;Annals of Oncology. 2017 Oct 1
11 citations
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology...
Steven J. Cohen, Bert H. O'Neil, Jordan Berlin, Patricia Ames, Marti McKinley, Julie Horan, Patricia M. Catalano, Angela M. Davies, Colin D. Weekes, Lawrence Leichman> ;Cancer Chemotherapy and Pharmacology. 2016 Feb 17
73 citations
Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent ...
Mario E. Lacouture, Mary Elizabeth Davis, Grace Elzinga, Nicholas Butowski, David Tran, John L. Villano, Lucianna DiMeglio, Angela M. Davies, Eric T. Wong> ;Seminars in Oncology. 2014 Jun 1
6 citations
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer
Cheryl Ho, Angela M. Davies, Randeep Sangha, Derick H Lau, Primo N. Lara, Helen K. Chew, Laurel A. Beckett, Philip C. Mack, Jonathan W. Riess, David R. Gandara> ;Investigational New Drugs. 2013 Sep 8
6 citations
Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma.
Derick H Lau, James J. Moon, Angela M. Davies, Rachel E. Sanborn, Fred R. Hirsch, Wilbur A. Franklin, Janet C. Ruzich, Mary W. Redman, David R. Gandara> ;Clinical Lung Cancer. 2013 Jul 1
112 citations
Tumor treating fields: a new frontier in cancer therapy.
Angela M. Davies, Uri Weinberg, Yoram Palti> ;Annals of the New York Academy of Sciences. 2013 Jul 1
15 citations
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors
Helen K. Chew, George Somlo, Philip C. Mack, Barbara J. Gitlitz, Regina F Gandour-Edwards, Scott D Christensen, Hannah M. Linden, Leslie J. Solis, X. Yang, Angela M. D...> ;Annals of Oncology. 2012 Apr 1
26 citations
A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California...
Barbara J. Gitlitz, Denice D. Tsao-Wei, Susan Groshen, Angela M. Davies, Marianna Koczywas, Chandra P. Belani, Athanassios Argiris, Suresh S. Ramalingam, Everett E. Vo...> ;Journal of Thoracic Oncology. 2012 Mar 1
30 citations
A phase I and pharmacokinetic study of oral 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: A...
Joseph Chao, Timothy W. Synold, Robert J. Morgan, Charles A. Kunos, Jeff Longmate, Heinz-Josef Lenz, Dean Lim, Stephen Shibata, Vincent Chung, Ronald G. Stoller, Chand...> ;Cancer Chemotherapy and Pharmacology. 2012 Mar 1
43 citations
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-...
Frank C. Richardson, G. David Young, Regina Sennello, Julie Wolf, Gretchen M. Argast, Peter Mercado, Angela Davies, David Epstein, Bret Wacker> ;Anticancer Research. 2012 Feb 1
25 citations
Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial
Randeep Sangha, Angela M. Davies, Primo N. Lara, Philip C. Mack, Laurel A. Beckett, Paul J. Hesketh, Derick H Lau, Tianhong Li, Natasha Perkins, David R. Gandara> ;Journal of Thoracic Oncology. 2011 Dec 1
9 citations
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: A California cancer consortium phase II study (NCI 7003)
Suresh S. Ramalingam, Angela M. Davies, Jeffrey Longmate, Martin J. Edelman, Primo N. Lara, Everett E. Vokes, Miguel A. Villalona-Calero, Barbara J. Gitlitz, Karen L. ...> ;Journal of Thoracic Oncology. 2011 Oct 1
11 citations
Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study
Cheryl Ho, Randeep Sangha, Laurel A. Beckett, Michael Tanaka, Derick H Lau, Daniel B. Eisen, Rachel A. Burich, Paul A. Luciw, Imran Khan, Philip C. Mack, David R. Gand...> ;Investigational New Drugs. 2011 Aug 1
Meta-analysis of the predictive and prognostic value of erlotinib-related biomarkers in phase III, placebo-controlled trials in non-small cell lung cancer (NSCLC): Rec...
Soulieres D, Wolf J, Shepherd FA, Cappuzzo F, Bunn PA, Herbst RS, Hirsch FR, Kerr KM, Mitsudomi T, Tsao MS, Yang C, Richardson FC, Klughammer B, Wacker B, Sternberg D,...> ;J. Clin. Oncol.. 2011-05-20
Phase I pharmacokinetic study of temsirolimus (CCI-779) in patients with advanced malignancies and normal and impaired liver function: An NCI Organ Dysfunction Working...
Sarantopoulos J, Lenz H, LoRusso P, Shibata S, Kummar S, Mulkerin D, Ramanathan RK, Mita MM, O'Rourke P, Remick SC, Goel S, Gutierrez M, Ramalingam SS, Murgo A, Davies...> ;J. Clin. Oncol.. 2011-05-20
31 citations
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Gr...
Ticiana Leal, Scot C. Remick, Chris H. Takimoto, Ramesh K. Ramanathan, Angela M. Davies, Merrill J. Egorin, Anne Hamilton, P. LoRusso, Stephen Shibata, Heinz-Josef Len...> ;Cancer Chemotherapy and Pharmacology. 2011 Apr 9
192 citations
Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed
D. Ross Camidge, Scott A. Kono, Xian Lu, Sonia Okuyama, Anna E. Barón, Ana B. Oton, Angela M. Davies, Marileila Varella-Garcia, Wilbur A. Franklin, Robert C. Doebele> ;Journal of Thoracic Oncology. 2011 Apr 1
57 citations
EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer.
Philip C. Mack, W. S. Holland, Rebekah A. Burich, Randeep Sangha, Leslie J. Solis, Yueju Li, Laurel A. Beckett, Primo N. Lara, Angela M. Davies, David R. Gandara> ;Journal of Thoracic Oncology. 2009 Dec 1
40 citations
Intermittent Erlotinib in Combination with Pemetrexed: Phase I Schedules Designed to Achieve Pharmacodynamic Separation
Angela M. Davies, Cheryl Ho, Laurel A. Beckett, Derick H Lau, Sidney A. Scudder, Primo N. Lara, Natasha Perkins, David R. Gandara> ;Journal of Thoracic Oncology. 2009 Jul 1
A phase II study of the halichondrin B analog, E7389, in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a taxane. A California...
Gitlitz BJ, Davies AM, Belani CP, Argiris A, Ramalingam SS, Hoffman PC, Koczwas M, Groshen SG, Gandara DR> ;J. Clin. Oncol.. 2009-05-20
Dual epidermal growth factor receptor (EGFR) inhibition: Phase I study combining cetuximab (C225) and erlotinib (E) in advanced solid tumors.
Sangha R, Ho C, Beckett L, Lau DH, Lara PN, Davies AM, Mack PC, Koslan GM, Holland WS, Gandara DR> ;J. Clin. Oncol.. 2009-05-20
1 citations
Erlotinib: applications in therapy and current status of research
Rachel E. Sanborn, Angela M. Davies> ;Expert Review of Clinical Pharmacology. 2009 Jan 1
64 citations
Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)
Angela M. Davies, Kari Chansky, Primo N. Lara, Paul H. Gumerlock, John Crowley, Kathy S. Albain, Stanley J. Vogel, David R. Gandara> ;Journal of Thoracic Oncology. 2009 Jan 1
Join now to see all

Press Mentions

Patient Visiting Suspended at Lincolnshire Hospital Due to Rising Covid-19 CasesOctober 28th, 2020
Mice Help Find the Right Chemotherapy Treatment for Cancer PatientsFebruary 3rd, 2017
Champions Oncology Announces Initiation of Prospective Correlative Trial in SarcomaJanuary 21st, 2016